ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
-1.83%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$7.59B
AUM Growth
-$2.04B
(-21%)
Cap. Flow
-$1.81B
Cap. Flow
% of AUM
-23.81%
Top 10 Holdings %
Top 10 Hldgs %
13.28%
Holding
1,986
New
640
Increased
343
Reduced
340
Closed
625
Top Buys
| 1 |
Ameren
AEE
|
+$168M |
| 2 |
Entergy
ETR
|
+$130M |
| 3 |
Danaher
DHR
|
+$116M |
| 4 |
PPL Corp
PPL
|
+$65.3M |
| 5 |
Cooper Companies
COO
|
+$61.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$359M |
| 2 |
CMS Energy
CMS
|
+$170M |
| 3 |
Duke Energy
DUK
|
+$164M |
| 4 |
Citigroup
C
|
+$116M |
| 5 |
Evergy
EVRG
|
+$113M |
Sector Composition
| 1 | Healthcare | 17.35% |
| 2 | Utilities | 13.04% |
| 3 | Financials | 12.38% |
| 4 | Technology | 11.27% |
| 5 | Consumer Discretionary | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Ultragenyx Pharmaceutical
RARE
$2.92B
| $289K | ﹤0.01% |
7,991
-79,026
| -91% | -$2.86M |
|
1177
New Mountain Finance
NMFC
$1.11B
| $288K | ﹤0.01% |
26,100
-191
| -0.7% | -$2.11K |
|
1178
Nuveen Churchill Direct Lending
NCDL
$758M
| $287K | ﹤0.01% |
16,900
-528
| -3% | -$8.97K |
|
1179
FirstCash
FCFS
$6.49B
| $285K | ﹤0.01% |
2,366
-21,771
| -90% | -$2.62M |
|
1180
AMERISAFE
AMSF
$841M
| $284K | ﹤0.01% |
5,400
-20,751
| -79% | -$1.09M |
|
1181
Coca-Cola Consolidated
COKE
$10.6B
| $284K | ﹤0.01% |
+2,100
| New | +$284K |
|
1182
Ameresco
AMRC
$1.44B
| $283K | ﹤0.01% |
23,425
-55,327
| -70% | -$668K |
|
1183
Farmers National Banc Corp
FMNB
$554M
| $282K | ﹤0.01% |
+21,574
| New | +$282K |
|
1184
Pulmonx
LUNG
$69.3M
| $282K | ﹤0.01% |
41,958
-6,089
| -13% | -$40.9K |
|
1185
Tyra Biosciences
TYRA
$667M
| $281K | ﹤0.01% |
+30,235
| New | +$281K |
|
|
NVEE
1186
DELISTED
NV5 Global
NVEE
| $280K | ﹤0.01% |
14,520
-43,970
| -75% | -$848K |
|
1187
Arbutus Biopharma
ABUS
$855M
| $277K | ﹤0.01% |
+79,500
| New | +$277K |
|
1188
BCE
BCE
$22.5B
| $276K | ﹤0.01% |
+12,013
| New | +$276K |
|
1189
Ingles Markets
IMKTA
$1.32B
| $269K | ﹤0.01% |
4,136
+876
| +27% | +$57K |
|
1190
Neurocrine Biosciences
NBIX
$14.1B
| $267K | ﹤0.01% |
2,414
-13,430
| -85% | -$1.49M |
|
1191
Cullinan Oncology
CGEM
$386M
| $266K | ﹤0.01% |
35,200
+11,700
| +50% | +$88.4K |
|
1192
Bumble
BMBL
$710M
| $265K | ﹤0.01% |
+61,134
| New | +$265K |
|
1193
Insteel Industries
IIIN
$749M
| $265K | ﹤0.01% |
+10,059
| New | +$265K |
|
1194
Danaos Corp
DAC
$1.73B
| $262K | ﹤0.01% |
+3,364
| New | +$262K |
|
1195
Fidelis Insurance
FIHL
$1.84B
| $261K | ﹤0.01% |
16,100
-84,769
| -84% | -$1.37M |
|
1196
Rackspace Technology
RXT
$347M
| $260K | ﹤0.01% |
153,897
-45,181
| -23% | -$76.3K |
|
1197
Gevo
GEVO
$404M
| $259K | ﹤0.01% |
223,363
+199,683
| +843% | +$232K |
|
1198
Humacyte
HUMA
$233M
| $259K | ﹤0.01% |
+151,854
| New | +$259K |
|
1199
Vivid Seats
SEAT
$110M
| $259K | ﹤0.01% |
4,381
+2,079
| +90% | +$123K |
|
1200
Bioventus
BVS
$484M
| $257K | ﹤0.01% |
28,119
+2,638
| +10% | +$24.1K |
|